Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis withPseudomonasAirway Infection

Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria

(2010) Antonia C. Kastoris et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic Fibrosis

(2010) Elliott C. Dasenbrook   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis

(2010) Christopher M. Oermann et al.   PEDIATRIC PULMONOLOGY

New Antimicrobial Strategies in Cystic Fibrosis

(2010) Mireille van Westreenen et al.   PEDIATRIC DRUGS

Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection

(2009) Alexandra L. Quittner et al.   CHEST

Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis

(2009) D. L. MacLeod et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Shifting patterns of inhaled antibiotic use in cystic fibrosis

(2008) Samuel M. Moskowitz et al.   PEDIATRIC PULMONOLOGY